Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Prednisolone Acetate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 known ✓ | P04150 | 9/20 | 0.78 |
| ▸ | HIF1A | Q16665 | 6/20 | 1.00 |
| ▸ | PGR | P06401 | 6/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.78 |
| ▸ | AR | P10275 | 3/20 | 0.78 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.78 |
| ▸ | SERPINA6 | P08185 | 2/20 | 0.78 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.78 |
| ▸ | TNF | P01375 | 1/20 | 0.78 |
| ▸ | IL6 | P05231 | 1/20 | 0.78 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.78 |
| ▸ | GLUL | P15104 | 1/20 | 0.78 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.78 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.78 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.78 |
| ▸ | LMNA | P02545 | 4/20 | 0.78 |
| ▸ | F2 | P00734 | 1/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.71 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.71 |
| ▸ | USP2 | O75604 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Prednisolone Acetate SCHEMBL13044467 | 1.00 | HIF1A (1.00) | HIF1APGRNR3C1CYP3A4AR | |
| Prednisolone Acetate SCHEMBL8000 | 1.00 | HIF1A (1.00) | HIF1APGRNR3C1CYP3A4AR | |
| Prednisolone Acetate SCHEMBL10118889 | 1.00 | HIF1A (1.00) | HIF1APGRNR3C1CYP3A4AR | |
| Prednisolone Acetate SCHEMBL9806574 | 0.97 | HIF1A (0.93) | HIF1APGRNR3C1CYP3A4AR | |
| Prednisolone Acetate SCHEMBL9806568 | 0.97 | HIF1A (0.93) | HIF1APGRNR3C1CYP3A4AR | |
| Prednisolone Acetate SCHEMBL9838659 | 0.93 | HIF1A (0.86) | HIF1APGRNR3C1CYP3A4AR | |
| SCHEMBL14867443 | 0.92 | HIF1A (0.85) | HIF1APGRNR3C1CYP3A4AR | |
| SCHEMBL9426742 | 0.92 | PGR (0.85) | HIF1APGRNR3C1CYP3A4AR | |
| SCHEMBL16009510 | 0.92 | HIF1A (0.91) | HIF1APGRNR3C1CYP3A4AR | |
| SCHEMBL4537969 | 0.91 | HIF1A (0.84) | HIF1APGRNR3C1CYP3A4AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 13248 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260115166-A1 | COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF PHOTORECEPTOR ROD DEGENERATIONS AND GENERATION OF PHOTORECEPTORS | PURDUE RESEARCH FOUNDATION (US) | 2026-04-30 | — | — | US | claimed |
| US-20260076872-A1 | POLYMER VIALS WITH SUBSTANTIALLY FLAT BOTTOMS AND INJECTION STRETCH BLOW MOLDING METHODS FOR MAKING THE SAME | SIO2 MEDICAL PRODUCTS LLC (US) | 2026-03-19 | — | — | US | claimed |
| CN-121586586-A | Process for preparing ophthalmic compositions of low solubility materials | 全福生物科技股份有限公司 | 2026-02-27 | — | — | CN | claimed |
| EP-4692785-A1 | PREPARATION LIQUID FOR ANALYZING HEMOGLOBIN COMPONENT, AND METHOD FOR MEASURING HEMOGLOBIN COMPONENT | Tosoh Corporation (JP) | 2026-02-11 | — | — | EP | claimed |
| EP-4676597-A2 | RIPASUDIL BASED OPHTHALMIC TREATMENTS | Kowa Company, Ltd. (US) | 2026-01-14 | — | — | EP | claimed |
| US-20250268918-A1 | METHODS FOR MAKING REDUCED PARTICLE SIZE COMPOUNDS | TAP PHARMACEUTICALS, AG (CH) | 2025-08-28 | — | — | US | claimed |
| US-20250268824-A1 | METHODS FOR MAKING REDUCED PARTICLE SIZE COMPOUNDS | TAP PHARMACEUTICALS AG (CH) | 2025-08-28 | — | — | US | claimed |
| US-20250268474-A1 | Systems and Methods for Detecting Fibrosis | 3HELIX, INC. (US) | 2025-08-28 | — | — | US | claimed |
| US-20250242092-A1 | SiOx BARRIER FOR PHARMACEUTICAL PACKAGE AND COATING PROCESS | SIO2 MEDICAL PRODUCTS INC (US) | 2025-07-31 | — | — | US | claimed |
| EP-4590283-A1 | MUCOADHESIVE DRUG DELIVERY SYSTEMS AND METHODS OF USE | Madd Ophthalmics Ltd. (CA) | 2025-07-30 | — | — | EP | claimed |
| US-4346709-A | Drug delivery devices comprising erodible polymer and erosion rate modifier | ALZA CORPORATION (US) | 1982-08-31 | — | — | US | claimed |
| US-4304765-A | Ocular insert housing steroid in two different therapeutic forms | ALZA CORPORATION (US) | 1981-12-08 | — | — | US | claimed |
| US-4271143-A | ACRYLIC POLYMER GEL | ALCON LABORATORIES, INC. (US) | 1981-06-02 | — | — | US | claimed |
| US-4244942-A | Creamy preparation containing steroid and process for the preparation thereof | TOKO YAKUHIN KOGYO KABUSHIKI KAISHA (JP) | 1981-01-13 | — | — | US | claimed |
| US-4136173-A | VEHICLES FOR OPHTHALMIC DRUGS | AMERICAN HOME PRODUCTS CORP. (US) | 1979-01-23 | — | — | US | claimed |
| US-4115544-A | DRUG PARTICLES MIXED WITH RELEASE RATE-CONTROLLING HOMOPOLYMER | ALZA CORPORATION (US) | 1978-09-19 | — | — | US | claimed |
| US-4014335-A | Ocular drug delivery device | ALZA CORPORATION (US) | 1977-03-29 | — | — | US | claimed |
| US-4001388-A | POLYESTERS | ALZA CORPORATION (US) | 1977-01-04 | — | — | US | claimed |
| US-3962414-A | Structured bioerodible drug delivery device | ALZA CORPORATION (US) | 1976-06-08 | — | — | US | claimed |
| US-3962430-A | Sterilization of solid non-electrolyte medicinal agents employing sodium chloride | MERCK & CO., INC. (US) | 1976-06-08 | — | — | US | claimed |